Table 2.
Adenocarcinoma types (n = 348)
| Histologic type | EGFR-mutant (n = 161) |
Wild-type (n = 187) |
P |
|---|---|---|---|
| Lepidic predominant adenocarcinomaa | 51 (31.7) | 45 (24.1) | |
| Papillary or acinar adenocarcinoma | 110 (68.3) | 92 (49.2) | |
| Other adenocarcinomasb | 0 (0) | 50 (26.7) | < 0.001 |
EGFR, epidermal growth factor receptor.
Data are presented as numbers (%).
a
Adenocarcinoma in situ, minimally invasive adenocarcinoma, or lepidic adenocarcinoma
b
Solid, invasive mucinous, enteric, micropapillary, or colloid adenocarcinoma